期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 194, 期 2, 页码 319-324出版社
WILEY
DOI: 10.1111/bjh.17537
关键词
myelodysplastic syndromes; patient-reported outcomes; fatigue; high-risk
类别
Incorporating patient-reported fatigue with traditional risk classification enhances survival prediction in higher-risk MDS patients, leading to distinct subgroups with different survival outcomes. This highlights the importance of considering patient-reported outcomes in refining overall survival predictions for higher-risk MDS.
The incorporation of patient-reported outcomes with traditional disease risk classification was found to strengthen survival prediction in patients with myelodysplastic syndromes (MDS). In the present Canadian MDS registry analysis, we validate a recently reported prognostic model, the Fatigue-International Prognostic Scoring System among higher-risk patients [FA-IPSS(h)], which incorporates patients' reported fatigue, assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life-Core 30 (QLQ-C30), with a threshold of >= 45 points, in higher IPSS score, stratifying them into distinct subgroups with different survival outcomes. We further validated this concept, using the Revised IPSS >3 center dot 5 as cut-off for the definition of higher-risk MDS, and patients' reported fatigue according to Edmonton Symptom Self-Assessment Scale (ESAS) Global Fatigue Scale (GFS), a single-item fatigue rating scale, which is easier to deploy. This emphasises the power of self-reported fatigue at refining overall survival predictions in higher-risk MDS and further bolsters the importance of considering patient-related outcomes in global assessments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据